Literature DB >> 31688365

A Patient-Centered Hepatitis B Virus (HBV) Educational Intervention Improves HBV Care Among Underserved Safety-Net Populations.

Robert J Wong1, Mandana Khalili2.   

Abstract

GOALS: To evaluate the impact of a prospective patient-centered hepatitis B virus (HBV) educational intervention on improving HBV care.
BACKGROUND: Improving patients' HBV knowledge has the potential to improve adherence to HBV monitoring and management, particularly among underserved safety-net populations.
METHODS: Consecutive chronic HBV adults at a single-center safety-net liver clinic were recruited from July 2017 to July 2018 to evaluate the impact of an in-person, language concordant formal HBV educational intervention on improvements in HBV knowledge and HBV management: appropriate HBV clinic follow-up (≥1 visit/year), HBV laboratory monitoring (≥1 HBV viral load and alanine aminotransferase test/year), hepatocellular carcinoma surveillance (≥1 liver imaging test/year among eligible patients), and HBV treatment among treatment eligible patients. HBV knowledge and management were assessed before and after the intervention and compared with age-matched and sex-matched HBV controls who did not receive an education.
RESULTS: Among 102 patients with chronic HBV (54.9% men; mean age, 52.0±13.8), HBV education improved HBV knowledge scores by 25% (P<0.001), HBV clinic follow-up from 25.5% to 81.4% (P<0.001), HBV laboratory monitoring from 62.8% to 77.5% (P=0.02), and appropriate HBV treatment from 71.5% to 98.5% (P<0.001). Compared with 102 HBV controls, receiving HBV education was associated with higher rates of HBV clinic follow-up (81.4% vs. 39.2%; odds ratio, 7.02; 95% confidence interval, 3.64-13.56; P<0.001) and appropriate HBV laboratory monitoring (77.5% vs. 42.2%; odds ratio, 4.94, 95% confidence interval, 2.64-9.24; P<0.001).
CONCLUSION: A formal, in-person, language concordant educational intervention leads to significant improvements in HBV knowledge, resulting in improved HBV monitoring and appropriate HBV treatment.

Entities:  

Mesh:

Year:  2020        PMID: 31688365      PMCID: PMC7744280          DOI: 10.1097/MCG.0000000000001276

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.174


  34 in total

1.  Evaluation of office-based intervention to improve prevention counseling for patients at risk for sexually acquired hepatitis B virus infection. Hepatitis B-WARE Study Group.

Authors:  H S Margolis; H H Handsfield; R J Jacobs; J E Gangi
Journal:  Am J Obstet Gynecol       Date:  2000-01       Impact factor: 8.661

2.  Hepatitis B management in vulnerable populations: gaps in disease monitoring and opportunities for improved care.

Authors:  Blaire E Burman; Nizar A Mukhtar; Brian C Toy; Tung T Nguyen; Alice Hm Chen; Albert Yu; Peter Berman; Hali Hammer; Daniel Chan; Charles E McCulloch; Mandana Khalili
Journal:  Dig Dis Sci       Date:  2013-09-20       Impact factor: 3.199

3.  Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.

Authors:  Ting-Tsung Chang; Yun-Fan Liaw; Shun-Sheng Wu; Eugene Schiff; Kwang-Hyub Han; Ching-Lung Lai; Rifaat Safadi; Samuel S Lee; Waldemar Halota; Zachary Goodman; Yun-Chan Chi; Hui Zhang; Robert Hindes; Uchenna Iloeje; Suzanne Beebe; Bruce Kreter
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

Review 4.  Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study.

Authors: 
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-03-27

5.  Can self-prediction overcome barriers to Hepatitis B vaccination? A randomized controlled trial.

Authors:  Anthony D Cox; Dena Cox; Rosalie Cyrier; Yolanda Graham-Dotson; Gregory D Zimet
Journal:  Health Psychol       Date:  2011-08-29       Impact factor: 4.267

6.  Assessment of HBV preventive services in a medically underserved Asian and Pacific Islander population using provider and patient data.

Authors:  Nizar A Mukhtar; Brian C Toy; Blaire E Burman; Albert Yu; Alice Hm Chen; Peter Berman; Tung Nguyen; Daniel Chan; Hali Hammer; Charles E McCulloch; Mandana Khalili
Journal:  J Gen Intern Med       Date:  2014-10-17       Impact factor: 5.128

7.  Factors associated with hepatitis B testing among Vietnamese Americans.

Authors:  Tung T Nguyen; Stephen J McPhee; Susan Stewart; Ginny Gildengorin; Lena Zhang; Ching Wong; Annette E Maxwell; Roshan Bastani; Vicky M Taylor; Moon S Chen
Journal:  J Gen Intern Med       Date:  2010-03-20       Impact factor: 5.128

8.  Integrating hepatitis prevention services into a substance use disorder clinic.

Authors:  Hildi Hagedorn; Eric Dieperink; Debra Dingmann; Janet Durfee; Samuel B Ho; Carl Isenhart; Nancy Rettmann; Mark Willenbring
Journal:  J Subst Abuse Treat       Date:  2006-12-12

9.  Hepatitis B prevention and care for Asian Americans, Native Hawaiians and Pacific Islanders at community health centers.

Authors:  Jeffrey B Caballero; Melinda Martin; Rosy Chang Weir; Nina Agbayani; Natalie Ah Soon; Katherine Chen
Journal:  J Health Care Poor Underserved       Date:  2012-11

Review 10.  Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis.

Authors:  Anna S F Lok; Brian J McMahon; Robert S Brown; John B Wong; Ahmed T Ahmed; Wigdan Farah; Jehad Almasri; Fares Alahdab; Khalid Benkhadra; Mohamed A Mouchli; Siddharth Singh; Essa A Mohamed; Abd Moain Abu Dabrh; Larry J Prokop; Zhen Wang; Mohammad Hassan Murad; Khaled Mohammed
Journal:  Hepatology       Date:  2015-11-13       Impact factor: 17.425

View more
  1 in total

1.  Fatty Liver and the Coronavirus Disease 2019 Pandemic: Health Behaviors, Social Factors, and Telemedicine Satisfaction in Vulnerable Populations.

Authors:  Rebecca G Kim; Sheyla P Medina; Catherine Magee; Mandana Khalili
Journal:  Hepatol Commun       Date:  2021-12-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.